Literature DB >> 31259870

How low can you go: Achieving postoperative outpatient pain control without opioids.

Vasiliy Sim1, Samuel Hawkins, Asaf A Gave, Alex Bulanov, Fady Elabbasy, Leen Khoury, Melissa Panzo, Elizabeth Sim, Stephen Cohn.   

Abstract

BACKGROUND: Postoperative outpatient narcotic overprescription plays a significant role in the opioid epidemic. Outpatient opioid prescription ranges from 150 to 350 oral morphine equivalent (OME) for a laparoscopic cholecystectomy or appendectomy, with 75 OME (10 pills of 5 mg of oxycodone) being the lowest recommendation (National Institute on Drug Abuse, 2018). We hypothesized that the addition of nonopioid medications to the outpatient pain control regimen would decrease the need for narcotics.
METHODS: In this prospective, observational pilot study, we prescribed a 3-day regimen of ibuprofen and acetaminophen to patients after uncomplicated laparoscopic cholecystectomies and appendectomies. An additional opioid prescription for 5 pills of 5 mg of oxycodone (37.5 OME) was written for breakthrough pain. During their postoperative visit, we evaluated patients' adherence to the pain control regime, their postdischarge opioid use, and the adequacy of their pain control.
RESULTS: Sixty-five patients were included in the study (52% male). The majority (80%) of surgeries were performed urgently or emergently. The visual analog scale pain score at home was significantly better than upon discharge (3.7 vs. 5.5, p = 0.001). The average number of oxycodone pills taken postdischarge was 1.8 pills. Half (51%) of the patients did not take any opioids. All but four patients reported that their pain was adequately controlled. No patient required additional opioid prescriptions or visited the emergency department.
CONCLUSION: This study demonstrated that opioids can be eliminated in at least half of the patients and that five pills of 5 mg of oxycodone (37.5 OME) is sufficient for outpatient pain control when a 3-day course of ibuprofen and acetaminophen is prescribed. LEVEL OF EVIDENCE: Therapeutic study, level V.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31259870     DOI: 10.1097/TA.0000000000002295

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  4 in total

1.  Multi-Modal Analgesic Strategy for Trauma: A Pragmatic Randomized Clinical Trial.

Authors:  John A Harvin; Rondel Albarado; Van Thi Thanh Truong; Charles Green; Jon E Tyson; Claudia Pedroza; Charles E Wade; Lillian S Kao
Journal:  J Am Coll Surg       Date:  2021-01-21       Impact factor: 6.113

2.  Patient-centered Opioid Prescribing: Breaking Away From One-Size-Fits-All Prescribing Guidelines.

Authors:  Josh Bleicher; Sean M Stokes; Benjamin S Brooke; Robert E Glasgow; Lyen C Huang
Journal:  J Surg Res       Date:  2021-03-18       Impact factor: 2.417

3.  Cross-Cultural Comparison of Nonopioid and Multimodal Analgesic Prescribing in Orthopaedic Trauma.

Authors:  Jason D Young; Abhiram R Bhashyam; Robert L Parisien; Quirine Van der Vliet; Rameez A Qudsi; Jacky Fils; George S M Dyer
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-05

4.  Pain management on a trauma service: a crisis reveals opportunities.

Authors:  Sabina Schaffer; Dunya Bayat; Walter L Biffl; Jeffrey Smith; Kathryn B Schaffer; Tala H Dandan; Jiayan Wang; Deb Snyder; Chris Nalick; Imad S Dandan; Gail T Tominaga; Matthew R Castelo
Journal:  Trauma Surg Acute Care Open       Date:  2022-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.